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Thymic-derived cells (T  cells)  1 and bone marrow-derived precursors of antibody- 
forming cells  (B  cells)  have  been  shown  to  cooperate in  the  antibody response to 
several antigens (1-3). Thus far, most weU-described forms of genetic control for the 
immune response appear to involve genes associated with T  cell rather than B  cell 
function (4). In contrast to B cells, there is no evidence to indicate that T  cells secrete 
antibody upon stimulation by antigen, and there are conflicting reports concerning 
whether T  cells have imlnunoglobulin on their surface (5-8).  Studies on the genetic 
control of the antibody response by B cells, therefore, would provide information on 
those genetic factors that (a) regulate the formation of antigen-specific  immunoglobulin 
receptors, and (b)  influence the rate of antibody synthesis. The antibody response of 
inbred mice  to Type III pneumococcal polysaccharide (SSS-III) provides an  ideal 
experimental model system for obtaining such information for a  number of reasons. 
First, cooperation between helper T ceils and B cells is not a requisite for the antibody 
response  to  this antigen  (9-11);  consequently,  the antibody response  to  SSS-III is 
considered to be largely a  B  cell response. Second, previous studies have shown that 
mice immunized with SSS-III produce mostly antibody of the IgM class (12-14); the 
avidity of this antibody for SSS-III remains essentially constant over a  10,000-fold 
range  of  immunizing  doses,  and  upon  reimmunization  with  high  or  low  doses  of 
antigen (15). Such homogeneity suggests that a  restricted population of B  cells par- 
ticipates in the antibody response to SSS-III; thus,  complexities associated with an 
antigen-mediated cell selection process (16) are greatly minimized. 
The  present  work  describes the  results  obtained in  preliminary studies  on 
the  genetic control of  the  antibody response  to  SSS-III. They  show  that  an 
X-linked gene plays a  decisive role in determining responsiveness to this anti- 
1  Abbreviations used in  this paper: ATS, anti-thymocyte serum;  B  cells, bone marrow- 
derived precursors  of  antibody-forming cells;  NIH,  National Institutes of Health; PFC, 
plaque-forming  cells; Pnc III, Type III pneumococci;  SRBC, sheep  erythrocytes; SSS-III, 
Type III pneumococcal polysaccharide; T cells, thymic-derived cells. 
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gen,  and  that  other  factors  influence  the  magnitude  of the  antibody  response 
produced. 
Materials  and Methods 
Animals.--BALB/cAnN,  C3H/HeN,  C57BL/6N,  NZB/BLN,  DBA/2N,  AKR/N,  and 
CBA/HN mice, as well as progeny derived from crosses involving BALB/cAnN and CBA/HN 
mice, were obtained from the Rodent and Rabbit Production Section of the National Institutes 
of Health  (NIH), Bethesda, Md. CBA/J mice were purchased from the Jackson Laboratory, 
Bar Harbor, Maine. CBA/H and CBA/H.T6T6  mice were generously provided by Doctors 
Lloyd Law and Michael Potter, National Cancer Institute, NIH, from a  colony maintained 
in their laboratory. All mice were 8-12 wk of age at the time of immunization. 
CBA/HN mice constitute a genetically distinct subline of CBA mice; they were established 
in  the  Genetics Unit of the Rodent and  Rabbit  Production  Section, NIH,  in  1966  from a 
pen-bred strain of CBA mice carrying the gene for foam cell reticulosis  (fro). Since the fm 
gene is lethal  (17), the initial stock of mice consisted of about six to eight carriers, i.e., mice 
heterozygous for fro; the fro gene arose as a  spontaneous mutation in the strain of CBA mice 
maintained at the Radiological Research Unit, Harwell, England. After a series of test matings 
were  conducted  to  determine  the  genotype of individuals,  homozygous normal  mice  were 
used to reestablish the inbred strain by brother-sister mating. The mice used in the present 
work  were  derived  from  parents  between  the  15th  and  25th  generation  of  brother-sister 
mating. However, during the initial stages of reestablishing an inbred strain, a severe reproduc- 
tive crisis occurred at about the seventh generation. As a result, the present colony of CBA/HN 
mice is derived from a single female who, fortunately, produced a litter composed of six females 
and one male. Presently, CBA/HN mice reproduce about as well as other inbred strains main- 
tained at NIH. 
The notation of Gill et al.  (18)  was used to designate parental strains of mice, as well as 
F1,  F2,  and backcross generations. BALB/cAnN and CBA/HN  mice were referred to as B 
mice and C mice, respectively. The first symbol used to describe a hybrid identifies the maternal 
member of a  cross, e.g., CB  mice are  F1  mice derived from a  cross between female C  mice 
and male B mice. For progeny derived from backcrosses, the symbol preceding the slash mark 
denotes the maternal member of the cross, e.g., CB/B mice are progeny derived from a back- 
cross between female CB  (FI mice) and male B  mice.  F2 mice are referred to as CB/CB mice. 
Anlige~z~ and  Immunization  Proced¢~res.--The  immunological  properties  of  the  SSS-III 
used, as well as the method by which it was prepared, have been described (12,  13,  15,  19); 
SSS-I and SSS-II were made by the same method. Unless indicated otherwise, mice were given 
a  single intraperitoneal injection (0.5/~g)  of these antigens in 0.5 ml of saline. The antibody 
response was assessed 5 days later. 
Mice immunized with sheep erythrocytes (SRBC) received a single intraperitoneal injection 
of known numbers of washed cells in 0.2 ml of saline. The antibody response was assessed 4 
days after immunization. 
Escherichia coli 0127 lipopolysaccharide B, Lot 478203, was purchased from Difco Labora- 
tories,  Detroit,  Mich.  Mice  were given  a  single intraperitoneal  injection  of  10  /~g  of  this 
antigen in 0.5 ml of saline. Serum  hemolytic antibody  titers were  determined 5  days  later. 
Immunological  Methods.--Serum  antibody and  splenic antibody-forming cells specific for 
SSS-III  were  detected  by  the  specific hemolysis of  SSS-III-coated  SRBC,  and  by  a  slide 
version of the technique of localized hemolysis-in-gel, respectively (12,  13).  SRBC were coated 
with SSS-III by the chromium chloride method  (20).  In studies on the antibody response to 
SRBC, SSS-I, and SSS-II, native SRBC  or SRBC coated with SSS-I or SSS-II by the chro- 
mium chloride method were used in the above serological tests. SRBC sensitized with alkali- 
treated  antigen  (21)  were used  for  the detection of serum hemolytic antibody  specific for 
1'2. c,li li,~opolysaceharide. AMSBAUGIt ET  AL.  933 
Serum antibody titers were expressed as  1/log2  of the highest dilution of antiserum pro- 
ducing complete hemolysis of a standard suspension of antigen-coated or native SRBC. Values 
for numbers of antibody-producing or plaque-forming cells (PFC) were  given as  log10 PFC/ 
spleen  and  lOgl0 PFC/10  s  spleen  cells.  For mice immunized with SSS-III, a  correction was 
made for the small number of SRBC-specific background PFC present (200-400/spleen), so 
that all values cited represent numbers of SSS-III-specific PFC detected (12,  13). 
Classification of Mice with Respect to Their Ability to Respond to SSS-I]I.--In  the genetic 
studies to be described, mice were classified as low, intermediate, or high responders to SSS- 
III.  C  mice regularly give an extremely low PFC  response to SSS-III; no serum hemolytic 
antibody can be detected in any of these mice after immunization with an optimally immuno- 
genic dose of antigen. All mice giving a C type of antibody response (Table III) were classified 
as low responders. B  mice produced the highest PFC and serum antibody response observed 
thus far; all mice giving a B type response (Table II) were classified as high responders. Other 
mice giving a  response greater than that of C  mice, but less than that of B  mice, were con- 
sidered to be intermediate responders. In crosses between B and C mice yielding low and either 
intermediate or high responders, mice having < 1000 PFC/spleen were classified as low re- 
sponders; only 2 of the 151 intermediate or high responders obtained in such cases, i.e.  mice 
having > 1000 PFC/spleen, had serum antibody titers < 1/log21. 
Statistical Procedures.--The results of this study were analyzed by three different statistical 
procedures. (a) The X  2 test (22) was used to determine whether the number of low responders 
derived  from  various crosses differed  significantly from  that expected  if responsiveness to 
SSS-III were transmitted as a  single X-linked genetic trait.  (b) A  two-tailed t  test (22)  was 
used to detect significant differences in the magnitude of the antibody response produced by 
intermediate  and/or  high responding  progeny  derived  from  different  crosses.  For  crosses 
yielding low as well as intermediate or high responders, all low responders were excluded from 
such comparisons. (c) The Kolmogorov-Smirnov two-sample test (23) was used to determine 
whether cumulative frequency distributions for the antibody response produced by only the 
intermediate and/or high responders derived from two different crosses differed significantly 
with respect to central tendency, dispersion, and skewness. Significant differences between two 
sample  distributions occur when  the largest  difference noted  at  any  0.2  log  test  interval 
(Dmax)  exceeds  that  expected  for  random  variations  between  two  sample  distributions 
drawn from the same population. 
It should be emphasized that the same data were subjected to analysis by both the two- 
tailed t test and the Kolmogorov-Smirnov two-sample test and that values for low responders 
were  excluded from such analyses. This was done to permit analysis of additional genetic 
factors which influence the magnitude of the antibody response produced by intermediate and 
high responders. In all of the above statistical procedures, differences were considered to be 
significant when probability values <0.05 were obtained. 
RESULTS 
Selection  of High  and Low Responding Strains  of Mice.--Several  strains  of 
inbred  mice  were  immunized  with  from  0.005  to  50/zg  of  SSS-III.  With  the 
exception of C3H/HeN  mice, a maximal antibody response was obtained 5 days 
after immunization  with 0.5 #g of antigen for all strains tested.  Consequently, 
this dose was used to assess the ability of various strains of mice to respond to 
SSS-III.  C3H/HeN  mice gave  an erratic response; in some experiments  (data 
not shown), an antibody response equal to, or greater than, that obtained with 
0.5  #g  of  SSS-III  was  produced  after  immunization  with  greater  or  lesser 
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The data of Table I show that the strains of mice examined differed markedly 
in their ability to respond to SSS-III. The average PFC response ranged from 
a low of 1880 PFC/spleen (CBA/J) to a  high of 14,800  PFC/spleen (B  mice) ; 
serum antibody titers from 1/log2 2.05  =t= 0.28 (DBA ~2N) to 1/log2 7.37  4- 0.17 
TABLE I 
Magnitude  of the PFC and Serum Antibody Response to 0.5 Ixg of SSS-I[I for Various 
Strains of Inbred  Mice* 
Strain  H-2 type  Sex  PFC/spleen  Serum titer  log10 ± $2  1/log~. =h: .S'Ya  No. of mice 
B mice  d  C  4.116  -4-  0.02  7.37  -4-  0.17  67 
(BALB/cAnN)  (12,900 ) 
9  4.170  -4-  0.02  7.31  ±  0.13  148  (133)~ 
(14,800) 
k  ?  4.048  4-  0.098  6.20  4-  1.32  5 
(11,2oo) 
--  9  3.743  4-  0.108  3.75  4-  0.25  4 
(5530) 
b  Y  3.725  4-  0.045  4.00  4-  0.00  5 
(5300) 
d  Y  3.611  i  0,094  7.80  4-  0.20  5 
(4080) 
d  c~  3.568  4-  0,093  4.28  ±  0.27  25 
(3700) 
9  3.324  4-  0.079  2.05  4-  0.28  40 
(211o) 
k  c~  3.553  4-  0.045  3.71  4-  0.29  58 
(3570) 
9  3.546  4-  0,055  4.80  4-  0.17  50 
(3560) 
k  9  3.513  ±  0,078  6.80  4-  0.27  25 
(3260) 
k  cP  3.276  4-  0.066  5.78  4-  0.34  22 
(1890) 
9  3.274  4-  0.092  4.47  4-  0.37  19 
(1880) 
C3H/HeN 
CBA/H. T6T6 
C57BL/6N 
NZB/BLN 
DBA/2N 
CBA/H 
AKI~/X 
CBA/J 
* Geometric means are shown in parentheses. 
{ No. of mice used for serum titer determinations. 
(B  mice)  were  obtained.  C3H/HeN,  CBA/H.T6T6,  C57BL/6N,  NZB/BLN, 
CBA/H, and AKR/N  mice gave intermediate responses. 
No direct relationship between H-2 type and the magnitude of the antibody 
response  to  SSS-III  was  evident.  Several  strains  of  H-2  k  mice  (CBA/H, 
AKR/N, and CBA/J) responded poorly; yet, C3H/HeN mice (H-2  k) responded 
almost  as  well  as  B  mice  (H-2e),  the  highest  responding  strain.  The response 
of  other  strains  of H-2  d mice was  more  like that  of low responding  CBA/H, 
AKR/N,  and  CBA/J mice (H-2  ~)  than  of B  mice (H-2d). AMSBAUGH ET  AL.  935 
Other strains of inbred mice were also tested for their ability to respond to 
SSS-]II (24); in no case was a response greater than that produced by B mice 
obtained. Since  the response produced by B mice may be typical of the upper 
limit of responsiveness to SSS-III in mice,  and since the antibody response to 
SSS-III in B mice has been well characterized (12, 13, 15,  19), these mice were 
used as high responders in the present work. Values for logt0 PFC/spleen,  logt0 
PFC/10  s spleen cells,  and  1/log2 serum  antibody titer  for B  mice  immunized 
with 0.5/~g of SSS-III are given in Table II; male and female B mice did  not 
differ significantly in their response to antigen (P  >  0.05,  two-tailed t test). 
CBA/HN or C mice produced an extremely low antibody response to SSS-III 
(Table III); no serum antibody could be detected in any of these  mice immu- 
TABLE II 
Magnitude  of the PFC and Serum Antibody Response  of Male and Female B Mice 
Immunized with 0.5 #g of SSS-III* 
PFC/spleen  PFC/106 spleen cells  1/log2 serum antibody titer 
Sex  Range and  Mean  Range and  Mean  Range and 
No. of mice  log10 -4- S~  No. of mice  logt0 =t= S~  No. of  Mean q- SY:  mice 
C  3650-31,250  4.11 ±  0.02  18-170  1.81 +  0.04  4-11  7.37  ±  0.17 
67  (12,900)  37  (65)  67 
2350-50,100  4.17 ±  0.02  12  234  1.86  ±  0.02  4-10  7.31  ±  0.13 
148  (14,800)  115  (73)  133 
* Geometric means are shown in parentheses. 
nized with 0.5/zg of antigen. In 55 of 64 male, and in 20 of 36 female C mice, 
no SSS-III-specitic PFC could be detected (values listed as  ~  100 PFC/spleen). 
Since values of 100-200 PFC/spleen are of questionable significance,  i.e.  they 
represent only 1-2 PFC more than background values fm SRBC-specific PFC, 
one may conclude that most of these mice failed to give an unequivocal anti- 
body response  to  SSS-III. The response  produced by remaining C  mice was 
considerably below that for B mice (Table II), and it was easy to distinguish 
mice giving a C-type response from those giving a B-type response. Female C 
mice tended to respond slightly better than males. 
Attempts were made to increase the magnitude of the antibody response to 
SSS-III in C mice under a variety of experimental conditions. These included 
(a)  immunization with different doses (0.005-50 #g) of SSS-III, (b) immuniza- 
tion with formalin-treated Type III pneumococci (Pnc III), and (c) treatment 
with from 0.003 to 0.5 Inl of anti-thymocyte serum (ATS)3 None of these pro- 
cedures  elevated  the  magnitude  of  the  response  produced.  In other  studies, 
class-specific  facilitating antisera (12)  failed to reveal the presence of SSS-III- 
2  Treatment with ATS has been shown to produce a significant increase in the magnitude 
of the antibody response to SSS-III in B mice and in other strains of mice tested (24-26). 936  GENETIC  CONTROL  OF  ANTIBODY  RESPONSE  TO  SSS-III 
specific PFC making  antibody of the IgM, IgG, or IgA class in C  mice given 
either  SSS-III or Pnc III. Also, C  mice did not appear to be cross-tolerant  to 
SSS-III since Type III-specific antisera,  obtained from either immunized rab- 
bits  or B  mice,  did not  agglutinate  erythrocytes or spleen  cells from C  mice. 
The addition of spleen cells  (or serum)  from C mice to spleen cells  (or sermn) 
from immunized B  mice provided no evidence to indicate that C mice produce 
a substance that interferes with the detection of SSS-III-specific PFC or se~um 
antibody.  In view of the  above findings,  C  mice were used  as low responders 
in the genetic studies to be described. 
Incidence of Low Responders among  Progeny Derwed from  Various Crosses.- 
The antibody response produced by CB mice illustrates  that major differences 
TABLE III 
Magnitude of tile PFC and Serum Antibody Response to 0.5 ~tg of SSS-III for Male and 
Female C Mice 
Immunological test  Range of values* 
No. of mice giving a  stated  response/ 
total No. of mice examined 
ce  ?~ 
PFC/spleen  < 100  55/64  20/36 
100-200  5/64  3/36 
200-500  4/64  6/36 
500-1000  0/64  7/36 
> 1000  0/64  0/36 
PFC/106 spleen cells  < 1  11/15  12/21 
1-10  4/15  7/21 
10-12  0/15  2/21 
1/log2 serum antibody titer  < 1  21/21  36/36 
* Numbers of SSS-IILspecific PFC or 1/log.2 serum antibody titer. 
in the ability of B  and  C  mice to respond to SSS-III are not governed by an 
autosomal dominant gene.  All male CB  mice gave a  low response  to SSS-III 
(Table  IV). In contrast,  female CB mice gave an intermediate,  rather  than  a 
high,  response  to  antigen;  the  magnitude  of  the  mean  serum  antibody  and 
PFC response was about one-half that obtained for B  mice (Table II). These 
findings suggest that a major component involved in the antibody response to 
SSS-III  is  X-linked,  i.e.,  carried  on  the  X  chromosome.  This  component 
appears to be present on the X  chromosome of high responding B  mice (X+X  + 
or X+Y),  but  not  of low-responding  C  mice  (X-X-  or X-Y);  3 according  to 
Lyon  (27),  CB  females  (X+X  -)  would  be  expected  to  give  an  intermediate 
response,  whereas  X+Y or X-Y  mice should be  high responders  and  low  re- 
sponders,  respectively.  To test  this hypothesis,  the  number of low responders 
3 The symbols X + and X- are used only to indicate the presence or absence of a hypo- 
thetical  X-linked  component  that we assume exerts  a  positive  influence on  the antibody 
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among progeny derived from several crosses was determined; these values were 
then compared with those expected if responsiveness  to SSS-III was transmit- 
ted as a single X-linked trait. The x 2 test was used to detect significant differ- 
ences  between  the  observed  values  and  those  expected  if  the  hypothesis  is 
TABLE IV 
Magnitude of the PFC and Serum Antibody Response Produced by Male and Female 
Progeny from  Various Crosses 
Mice  No. of  Hypothetical 
mice*  genotype 
CB  83/83  X-Y 
63/63  X+X  - 
CB/CB  44/95  X-Y 
51/95  X+Y 
51/94  X-X- 
43/94  X+X  - 
B/CB  36/36  X+Y 
CB/B 
34/34  X+X  - 
7/11  X-Y 
4/11  X+Y 
28/28  (X+X+,X+X  -) 
C/CB  36/36  X-Y 
29/29  X-X- 
CB/C  28/54  X-Y 
26/54  X+Y 
18/45  X-X- 
27/45  X+X  - 
Range 
PFC/spleen  PFC/106 spleen cells  1/log2 serum 
antibody titer 
Mean 
logl0 4- S~  Range  Mean 4- S~ 
< I00-100 
2200-20,450 
<100-550 
1650-25,650 
<100-550 
2000-19,850 
3300-45,000 
1300-27,700 
< 100-100 
4750-20,200 
650-24,450 
< 100-400 
< 100-200 
< 100-100 
4000-24,600 
<100-200 
1500-16,000 
Mean 
Range  loglo -4- S~[ 
N.C.§  <0.5-1  N.C.  <1[]  N.C. 
3.90  4-  0.03  6-152  1.62  4-  0.03  5-11¶  6.75  4-  0.27 
(7940)  (42) 
N.C.  <0.5-8  N.C.  <II[  N.C. 
4.05  -4- 0.03  15-176  1.79  4-  0.03  3-9**  5.69  ±  0.25 
( 11,200)  (62) 
N.C.  <0.5-3  N.C.  <111  N.C. 
3.86  4- 0.04  10-143  1.67  4- 0.04  4-9  5.79  4- 0.20 
(7240)  (47) 
4.16  4- 0.04  14-213  1.88  4-  0.04  5-10  6.89  4- 0.22 
(14,500)  (76) 
3.94  4-  0.05  10-166  1.67  4- 0.05  5-9  6.59  4- 0.22 
(8710)  (47) 
N.C.  <0.5-0.5  N.C.  <1[]  N.C. 
--  30-89  --  6-8  -- 
3.91  4-  0.07  3-143  1.64  q- 0.07  4-10  6.68  4-  0.27 
(8130)  (44) 
N.C.  <0.5-3  N.C.  <lr[  N.C. 
N.C.  <0.5-3  N.C.  <1]1  N.C. 
N.C.  <0.5-0.8  N.C.  <111  N.C. 
4.03  4- 0.03  23-182  1.72  -4- 0.04  5-9  6.38  4- 0.19 
(10,700)  (53) 
N.C.  <0.5-3  N.C.  <llI  N.C. 
3.76  4- 0.05  10-123  1.59  4- 0.05  4-9  5.56  4- 0.25 
(5750)  (39) 
* No. of mice giving a stated response/total No. of mice examined. 
Geometric means are shown in parenthesis. 
§ Not calculable, since no PFC or serum antibody could be detected in all but a  few of the mice examined. 
II No serum antibody detected in any of the mice examined. 
¶ Does not include three values of <1. 
** Does not include two values of <1. 
valid. The data of Table V dearly show that in all of the crosses examined, the 
number of low responders observed agreed with that expected for an X-linked 
trait  (P  >  0.05 using a X  2 test for all comparisons). In view of these findings, 
it is reasonable to assume that the hypothesis advanced is valid. The symbols 
X +  and  X-  will,  therefore,  be  used  in  subsequent  sections  of this  report  to 
classify progeny derived from various crosses with respect to gene dose for the 
X-linked  gene,  and  to facilitate  analysis of autosomal factors involved in the 
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Analysis of Cumulative Frequency Distributions.--If the above X-linked com- 
ponent is the only factor which accounts for differences in the ability of C and B 
mice to respond to SSS-III, then all mice having the same hypothetical geno- 
type,  with  respect  to  the  X-linked  component,  should  respond  similarly  to 
antigen. The data of Tables VI-X, which permit one to compare the response 
produced by one group of mice with  that of any other group listed,  indicate 
that this is not the case. 
Cumulative frequency distributions  for only the  intermediate  and high  re- 
sponders derived from various crosses were compared; the results of such corn- 
TABLE  V 
Incidence of Low Responders in Progeny Derived  from Various Crosses* 
Mice  Sex  Observed  Expected 
CB  C  83/83  83/83 
0/63  0/63 
CB/CB  C  44/95  47.5/95 
9  51/94  47/94 
B/CB  C  0/36  0/36 
0/34  0/34 
CB/B  C  7/11  5.5/11 
0/28  0/28 
C/CB  C  36/36  36/36 
9  29/29  29/29 
CB/C  C  28/54  27/54 
?  18/45  22.5/45 
* Values listed represent No. of low responders observed or expected/total  No. of mice 
examined. 
parisons are summarized in Tables VI and VII. When distributions for all male 
responders (X+Y mice) were compared (Table VI), four significant differences 
were found for the serum antibody response; these were not  accompanied by 
significant  differences  in  distribution  for  the  PFC  response.  For  CB/C  and 
B/CB  males,  the  distributions  for PFC  per  106  spleen  ceils,  but not  for the 
serum antibody response, differed significantly. With respect to PFC per spleen, 
no significant differences were noted among all distributions considered. 
Except  for  B/CB  females,  the  cumulative  frequency  distributions  for  all 
females  giving  an  intermediate  response  (X+X  -  mice)  differed  significantly 
from those giving a high response, i.e., X+X  + or B mice (Table VII); however, 
B/CB  females did not differ from B  females with respect to two of three im- 
munological parameters (PFC per 106 spleen cells and serum antibody). Com- 
parisons involving CB/B females presented a problem; here, both intermediate 
(X+X  -) and high (X+X  +) responders were present within the same population. 
Because  of  overlap  in  the  distributions  of  the  responses  produced  by  both 
types of mice, one could not classify individuals as either intermediate or high AMSBAUGH  ET  AL.  939 
responders. Thus, the distributions for CB/B females are not typical of popu- 
lations composed exclusively of intermediate or high responders. If one excludes 
all comparisons made involving B  and CB/B females, no significant differences 
were noted with respect  to  the  PFC  response for  remaining groups of mice; 
however, three significant differences were noted in distributions for the serum 
antibody response. 
TABLE  VI 
Comparison of Maximal  Di~erences between Cumulative Frequency Distributions for  Three 
Immunological Parameters  among Various Groups of Male Intermediate and High Responders* 
No. of mice  Hypothetical  Mice 
genotype 
Mice 
B  B/CB  CB/CB  CB/C 
loglo PFC/spleen 
67  X+Y  B  --  0.11  0.09  0.12 
36  X+Y  B/CB  0.11  --  0.17  0.23 
51  X+Y  CB/CB  0.09  0.17  --  0.06 
26  X+Y  CB/C  0.12  0.23  0.06  -- 
loglo PFC/IO  6 spleen cells 
36  X+Y  B  --  0.13  0.04  0.27 
36  X+Y  B/CB  0.13  --  0.12  0.40* 
51  X+Y  CB/CB  0.04  0.12  --  0.28 
26  X+Y  CB/C  0.27  0.40"  0.28  -- 
1~log2 serum antibody titer 
67  X+Y  B  --  0.31"  0.47*  0.42* 
36  X+Y  B/CB  0.31"  --  0.37*  0.16 
51  X+Y  CB/CB  0.47*  0.37*  --  0.30 
26  X+Y  CB/C  0.42"  0.16  0.30  -- 
* Cumulative frequency distributions were constructed from the data  of Table IV. The 
figures listed above represent Dmax values for comparisons made between two groups of mice. 
Significant differences are indicated by an asterisk. Except for CB/C mice, the Y chromo- 
some came from B mice in all cases. 
Analysis of the Magnitude of the Antibody Response.--When the magnitudes 
of the  antibodv response produced by all high responding males (X÷Y mice) 
were  compared,  three,  one,  and  three  significant differences  were  noted  for 
PFC per spleen, PFC per  106 spleen cells,  and the serum antibody response, 
respectively (Table VIII) ; in no comparisons were significant differences among 
males demonstrable for all three immunological  parameters. The magnitude of 
the  antibody response for  high  responding B  females  (X+X  +  mice)  differed 
significantly from that for all intermediate responders  (X+X  -  mice) with re- 
spect  to  all  three  immunological parameters  (Table IX).  If one excludes  all 
comparisons made involving B females, two and six additional significant dif- 
ferences were noted with respect to PFC per spleen and the serum antibody 
response,  respectively.  When  one  considers  all  comparisons cited  in  Tables 940  GENETIC  CONTROL  OF  ANTIBODY  RESPONSE  TO  SSS-III 
VI-IX,  there  is  only one  case  (the  serum  antibody  response  for  B/CB  vs.  B 
males)  in  which  a  significant  difference  in  distribution  was  not  accompanied 
by a  significant difference in the magnitude  of the antibody response. However, 
significant differences in the magnitude  of the response were not  accompanied 
by  significant  differences in  the distribution in  several  cases.  More  significant 
TABLE  VII 
Comparison  of  Maximal  Differences  between Cumulative  Frequency  Distributions  for  Three 
Immunological  Parameters  among  Various  Groups of Female Intermediate  and Itigh 
Responders* 
No. of 
mice 
148 
28 
34 
43 
63 
27 
115 
28 
34 
43 
63 
27 
133 
28 
34 
43 
63 
27 
Hypothetical 
genotype 
x+x + 
(x+x+,x+x) 
X+X  - 
X+X  - 
X+X  - 
X+X  - 
x+x + 
(X+X+,X+X  -) 
X+X  - 
X+X  - 
X+X  - 
X+X  TM 
x+x + 
(X+X+,X+X  -) 
X+X  - 
X+X  - 
X+X  - 
X+X- 
Mice 
B 
CB/B 
B/CB 
CB/CB 
CB 
CB/C 
B 
CB/B 
B/CB 
CB/CB 
CB 
CB/C 
B 
CB/B 
B/CB 
CB/CB 
CB 
CB/C 
Mice 
B  CB/B  [  B/CB  CB/CB  ]  CB 
0.36* 
0.35* 
0.50* 
0.48* 
0.61" 
r 
0.30* 
0.22 
0.29* 
0.39* 
0.44* 
0.21 
0.23 
0.48* 
0.21" 
0.57* 
0.36* 
0.09 
0.24 
0.22 
0.35 
loglo PFC/spleen 
0.35*]  0.50* 
O. 09  O. 24 
--  O. 20 
0.20 
0.18  0.13 
0.31  0.19 
0.48* 
0.22 
0.18 
0.13 
O.23 
loglo PFC/IO  ~ spleen cells 
0.30*  0.22  0.29*  0.39* 
--  0.08  0.09  0.12 
0.08  0.07  0.17 
0.09  0.07  --  0.13 
0.12  0.17  0.13  -- 
0.14  0.22  0.15  0.05 
1~log2 serum  antibody titer 
0.21  0.23  0.48*  0.21" 
--  0.04  0.34*  0.14 
0.04  --  0.30  0.15 
0.34*  0.30  --  0.31" 
0.14  0.15  0.37*  -- 
0.42*  0.38*  0.09  0.41" 
CB/C 
0.61" 
0.35 
0.31 
0.19 
0.23 
0.44* 
0.14 
0.22 
0.15 
0.05 
0.57* 
0.42* 
0.38* 
0.09 
0.41" 
* Cumulative frequency distributions were  constructed from the data of Table IV. The 
figures listed above represent Drnax values for  comparisons  made between  two  groups  of 
mice. Significant differences are indicated by an asterisk. 
differences were noted with comparisons based on the serum  antibody than on 
the PFC  response. 
Significant differences  were  noted for  most  comparisons  made  for  the  PFC 
and serum antibody response of X+X -  and X+Y mice; these mice were identical 
for gene dose with respect  to  the X-linked component  (Table X).  In contrast 
to  the  data  of  Tables  VI-IX,  more  significant  differences  were  detected  for 
comparisons  based  on  the  PFC  than  on  the  serum  antibody  responses.  In 
several  cases,  significant  differences  were  noted  for  all  three  immunological 
parameters  considered. AMSBAUGH  ET  AL.  941 
Magnitude of the Anlibody  Response to Other Anligens.--The  data of Table 
XI  show  that  the  direct  PFC  and  serum  hemolytic  antibody  responses  to 
SRBC were lower in C than in either B or CBA/J mice; as was the case for the 
antibody response to SSS-III, CB mice gave an intermediate response. B mice 
responded well to SSS-I, SSS-II, and E. coli 0127 lipopolysaccharide; however, 
no serum hemolytic antibody could be detected in C mice immunized with these 
antigens. CBA/J mice gave a good response to E. coli lipopolysaccharide. 
TABLE  VIII 
Comparison  of the magnitudes of the PFC and Serum Antibody Response to 0.5 #g of 
SSS-III  among  Various Groups of Male Intermediate and High Responders 
Hypo-  Mice 
No. of  Mean  4-  SY:*  thetical  Mice$ 
mice  genotype  B  B/CB  CB/CB  CB/C 
lo~o PFC/sfleen 
67  4.11  4-  0.02  X+Y  B  --  NS§  NS  P  <  0.05 
36  4.16  4-  0,04  X+Y  B/CB  NS  --  P  <  0.05  P  <  0.05 
51  4.05  4-  0,03  X+Y  CB/CB  NS  P  <  0.05  --  NS 
26  4.03  4-  0.03  X+Y  CB/C  P  <  0.05  P  <  0.05  NS  -- 
logio PFC/IO  6 spleen cells 
37  1.81  4-  0.04  X*Y  B  --  NS  NS  NS 
36  1.88  4-  0.04  X+Y  B/CB  NS  --  NS  P  <  0.05 
51  1.79  4-  0.03  X+Y  CB/CB  NS  NS  -  NS 
26  1.72  4-  0.04  X+Y  CB/C  NS  P  <  0.05  NS  -- 
1~log2 serum antibody tiler 
67  7.37  4-  0.17  X*Y  B  --  NS  P  <  0.05  P  <2  0.05 
36  6.89  4-  0.22  X+Y  B/CB  NS  --  P  <  0.05  NS 
51  5.69 4- 0.25  X~Y  CB/CB  P  <  0.05  P  <  0.05  --  NS 
26  6.38  4-  0.19  X*Y  CB/C  P  <  0.05  NS  NS  -- 
* Geometric  means  for PFC  values are  listed in Table  IV. 
~c Except  for CB/C mice,  the Y  chromosome  comes from B  mice  in all cases. 
§ No  significant  difference. 
DISCUSSION 
Although several strains of inbred mice were found to differ widely in their 
ability  to  respond  to  SSS-III,  all  strains  examined,  with  the  exception  of 
C3H/HeN mice,  showed  a  single  optimal dose  of antigen  for immunization; 
there was no relationship between H-2 type and the magnitude of the PFC and 
serum  antibody  responses produced  (Table I).  Both  of these findings  are in 
agreement with the work of Braley and Freeman (28), who obtained antibody 
responses of similar magnitude using related strains of mice and another prep- 
aration of SSS-III. The antibody response of BALB/cAnN or B mice has been 
well characterized  and  appears to be representative of the upper limit of re- 
sponsiveness to SSS-III in mice  (12,  13,  15,  19).  Consequently,  B  mice were 
used as high responders in the present work. 
Several strains of nfice responded poorly to SSS-III; however, the antibody 
response of CBA/HN or C  mice was extremely low (Table III). Unlike other 
strains of mice examined, no serum antibody could be detected in any of these 942  GENETIC  CONTROl,  OF  ANTIBODY  RESPONSE  TO  SSS-III 
mice after immunization with an optimally immunogenic dose of antigen.  Im- 
munization with various doses of either  SSS-III or Ty'pe  III pneumococci,  as 
well  as treatment with ATS, failed  to increase the magnitude of the response 
produced. No evidence was obtained to indicate  that  C mice either are cross- 
tolerant to SSS-III,  or produce a substance that interferes  with the detection 
of SSS-III-specific  antibody or PFC.  Therefore,  C mice were considered to be 
TABLE  IX 
Compariwn of the Magnitudes ef the PFC and Serum  AntiOody  Response  to 0.5 jzg of  SSS-III 
among  Various Groups of Female  Intermediate and High  Responders 
I 
mi  NO~-ce  Mean  ::3- .~X* 
148  4.17  4-  0,02 
28  3.91  4-  0,07 
34  3.94  4-  0,05 
43  3.86  4-  0,04 
63  3.90  4-  0.03 
27  3.76  4-  0.05 
115  1.86  -4-  0.02 
28  1.64  4-  0.07 
34  1.67  4-  0.05 
43  1.67  4-  0.04 
63  1.62  4-  0.03 
27  1.59  4-  0.05 
133  7.31  4-  0.13 
28  6.68  4-  0.27 
34  6.59  4-  0.22 
43  5.79  4-  0.20 
63  6.75  4-  0.27 
27  5.56  =:= 0.25 
ttypo- 
,  thetical 
genotype 
X+X + 
(X+X +, 
X+X  -) 
X+X 
X+X  - 
X+X  - 
X*X 
X+X  + 
(X+X  +, 
X+X  -) 
X+X - 
X*X- 
X*X- 
X+X - 
X#X  + 
(X*X +, 
X*X  ) 
X+X - 
X+X 
X+X 
X+X  - 
Mice 
B 
CB/B 
B/CB 
CB/CB 
CB 
CB/C 
B 
CB/B 
B/CB 
CB/CB 
CB 
CB/C 
B 
CB/B 
B/CB 
CB/CB 
CB 
CB/C 
Mice 
B  CB/B  B/CB  I  CB/CB  ]  CB  i  CB/C 
P  <0.05 
P  <  0.05 
P  <  0.05 
P  <  0.05 
P  <  0.05 
P  <  0.05 
P  <0.05 
P  <  0.05 
P  <  0.05 
P  <  0.05 
P  <0.05 
P  <  0.05 
P  <  0.05 
P  <  0.05 
P  <  0.05 
P  <  0.05 
NS 
NS 
NS 
NS 
P  <  0.0.5 
NS 
NS 
NS 
NS 
P  <  0.05 
NS 
P  <0.05 
NS 
P  <  0.05 
log~o P1;C/spleen 
P  <  0.05  P  <  0.05 
NS~  NS 
--  NS 
NS  ,  -- 
NS  ]  NS 
P  <  o.o5  k  NS 
logl,; PFC/10 e' spleen cells 
P  <  0.05  P  <  0.05 
NS  NS 
NS 
NS 
NS  NS 
NS  NS 
1~log2 ser2on antibody titer 
P  <  0.05  P  <  0.05 
NS  P  <  0.05 
--  I  P  <  0.05 
P  <  0.05  ]  --- 
NS  P  <  0.05 
P  <  0.05  SN 
P  <  0.05  I  P<0.05 
NS  NS 
NS  P  <  0.05 
NS  i  NS 
--  P  <  0.05 
I e<0.05  i  - 
P  <  0.05  I P  <  0.05 
NS  f  NS 
NS  J  NS 
NS  '  NS 
I  NS 
NS 
P  <  0.05  I  P  <  0.05 
NS  ~ P  <  0.05 
NS  P  >  0.05 
P  <_ 0,05  P  2:.05 
P  <  0.05  -- 
* Geometric  means for PFC  values are  listed  in Table IV. 
{ No significant  difference. 
low responders, and were used in conjunction with high responding B  mice in 
the genetic studies described. 
The results of this work clearly show that the antibody response to SSS-III 
in B  and C mice is governed by at least two distinct  types of genetic control. 
The first type influences the ability to respond to SSS-III in an almost quantal 
or "all-or-none"  manner;  the incidence  of low respondels  among progeny de- 
rived from various crosses indicates that responsiveness to SSS-III is controlled 
largely by  a gene present on the X  chromosome (Table V).  The second type 
appears to regulate the magnitude of the antibody response produced by both 
male and female mice possessing the X-linked gene. The data of Tables VI-X AMSBAUGtt  ET  AL.  943 
illustrate that for mice identical with respect to gene dose for the X-linked com- 
ponent,  significant differences in the magnitude of the PFC response were not 
always accompanied by significant differences in the magnitude of the serum 
antibody response, and conversely. Such quantitative effects may be mediated 
by autosomal genes that act independently to regulate (a) the number of anti- 
body-forming cells found after immunization with SSS-III, and (b) the amount 
of antibody made by such cells. 
TABLE X 
Comparison of the Magnitudes of the PFC and Serum Antibody Response to 0.5 Izg of SSS-III 
among X+Y and X+X  -  Mice* 
X+Y mice 
X+X  mice 
B  B/CB  CB/CB  CB/C 
loglo PFC/spleen 
CB/B:~  <0.05  <0.05  <0.05  NS§ 
B/CB  <0.05  <0.05  <0.05  NS 
CB/CB  <0.05  <0.05  <0.05  <0.05 
CB  <0.05  <0.05  <0.05  <0.05 
CB/C  <0.05  <0.05  <0.05  <0.05 
loglo PFC/IO  6 spleen cells 
CB/B~  <0.05  <0.05  <0.05  NS 
B/CB  <0.05  <0.05  <0.05  NS 
CB/CB  <0.05  <0.05  <0.05  NS 
CB  <0.05  <0.05  <0.05  NS 
CB/C  <0.05  <0.05  <0.05  <0.05 
l/log2 serum antibody titer 
CB/B:~  <0.05  NS  <0.05  NS 
B/CB  <0.05  NS  <0.05  NS 
CB/CB  <0.05  <0.05  NS  NS 
CB  NS  NS  <0.05  NS 
CB/C  <0.05  <0.05  NS  <0.05 
* Mean 4- Sg values of Table IV were used to obtain the probability values shown. 
Both X+X  + and X+X  -  were present in this group. 
§ No significant difference. 
It is tempting  at  this point to propose that  genes  governing the  structure 
and synthesis by B  cells of antibody specific for  SSS-III are X-linked. How- 
ever, several observations tend to weaken, but not necessarily exclude, such an 
argument.  First, Braley and Freeman (28)  reported that the ability of strains 
of inbred mice to respond well to SSS-III is transmitted as an autosomal domi- 
nant trait; the quantitative effects observed in their work are similar to those 
described  in  the  present  study.  It  remains  to  be  established whether  these 
effects can be ascribed solely to differences with respect to gene dose for auto- 
somal dominant genes that govern the ability of B  cells to produce  antibody 
specific for SSS-III, or to the action of a  separate homeostatic control mech- 944  GENETIC  CONTROL  OF  ANTIBODY  RESPONSE  TO  SSS-III 
anism in which thymus cells appear to exert a negative, rather than a positive, 
influence on the expression of such genes (25); such a  control mechanism will 
be considered later.  Second,  C  mice give an extremely low,  or undetectable, 
IgM antibody response, not only to SSS-III, but also to SRBC and to several 
TABLE  XI 
Magnit¢de of the PFC and Serum A ntibody Responses PrGduced by B, C, CB, and CBA/J Mice 
to Other Antigens* 
Antigen and dose 
SRBC, 2 X  109 
SRBC, 5 X  109 
SSS-I, 0.5/~g 
SSS-II, 0.5 #g 
E. coli lipopoly- 
saccharide, 10 #g 
Time  I 
aOsfay:~  Mice 
-d  's 
B 
C 
CB 
CBA/J 
4  B 
! 
C 
5  B 
C 
5  B 
C 
5  B 
C 
CBA/J I 
PFC/spleen  [ PFC/10~ spleen cells 
logt0 4- $2  oge 4- S~ 
5.395  4-  0.038  2.958  4-  0.033 
(248,000)§  (907) 
3.625  4-  0.182  2.160  4-  0.124 
(4400)  (145) 
5.181  4-  0.052  2.891 4-  0.062 
(152,000)  (779) 
5.287  4-  0.062 
(194,000) 
5.432  ±  0.047 
(270,000) 
3.744  4-  0.162 
(5550) 
m 
2.987  4-  0.079 
(970) 
1.912  -t- 0.091 
(81) 
I/log2 serum 
antibody4-S~ 
10.00  4-  0.33 
4.00  4-  0.27 
7.80  4-  0.37 
11.50  i  0.29 
9.50  ±  0.43 
4.00  ±  0.22 
7.20  4-  0.37 
None 
detected 
5.75  4-  0.63 
None 
detected 
6.20  -4- 0.58 
None 
detected 
7.83  4-  0.17 
* Five to eight mice were used to obtain all values listed. 
:[: Days after immunization. 
§ Geometric means are shown in parentheses. 
polysaccharide antigens (Table XI). While it is possible that the ability to re- 
spond to several polysaccharide antigens is governed by an array of X-linked 
genes, not present in C  mice, the results of preliminary studies reveal that the 
IgM levels of C  mice,  as well as other low  responders used in this work,  are 
significantly lower than those of intermediate and high responders. This sug- 
gests  that  the  above X-linked gene may constitute (a)  a  controller gene for A~SBAUGH ET AL.  945 
IgM synthesis, or (b) govern the formation of a product, perhaps a hormone, 
that regulates the expression of a controller gene located on another chromo- 
some. In this context, it has been reported recently that the X  chromosome of 
man carries a gene that markedly influences serum IgM levels (29). Since mostly 
antibody of the IgM class is produced in mice after immunization with SSS-III 
(12-14),  such  a  gene could exert a  secondary yet decisive influence in deter- 
mining responsiveness not only to SSS-III, but also to other antigens that elicit 
primarily an IgM antibody response. At present we are attempting to define 
the precise nature of the genetic defect observed in C mice. Clearly, studies on 
the antibody response of C mice to other antigens would enable one to deter- 
mine whether this genetic defect affects all IgM antibody responses. If this is 
the case, then C mice may provide a suitable experimental model system for the 
study of certain primary immune deficiency diseases of man, several of which 
have been reported to be X-linked  (30-34). 
If the above X-linked gene acts primarily to regulate IgM formation, then 
the differences noted in the magnitude of the antibody response of mice having 
the X-linked gene may be attributed to differences in gene dose with respect 
to autosomal dominant genes that govern, in a positive manner, the ability of 
B cells to synthesize antibody specific for SSS-III; such genes would, of course, 
be  cryptic in  C  mice  lacking  the  X-linked  gene,  but  expressed  in  progeny 
derived from several of the crosses considered in this work. If such is the case, 
then one might assume that high responding B mice are dominant for one or 
more of these genes, and that low responding C mice are recessive for any or all 
of them. Accordingly, B/CB and intermediate and high responding CB/B mice 
would be expected to give a similar antibody response to SSS-III and be among 
the highest responders; in contrast,  intermediate and high responding CB/C 
mice  should  give  the  lowest  response produced  among  all  mice  having  the 
X-linked gene; the data of Tables IV-IX are consistent with such a view. Alter- 
natively, C mice and B mice may be identical in gene dose for such autosomal 
dominant genes, and the quantitative differences observed among mice having 
the X-linked gene may be the result of factors that exert a negative rather than 
a positive influence on their expression. Previous studies have shown that treat- 
ment with ATS results in an 8-10-fold increase in the magnitude of the anti- 
body response to SSS-III (24-26); such increases are considerably greater than 
the quantitative differences noted in this work. While the infusion of syngeneic 
thymus cells abrogated the enhancement produced after treatment with ATS, 
the infusion of syngeneic peripheral white blood cells further increases the mag- 
nitude of the response (25). On the basis of these findings, we proposed that 
two types of presumably thymic-derived cells (a suppressor cell and an ampli- 
fier cell) act in an opposing manner to regulate the magnitude of the antibody 
response to SSS-III. The ability of ATS to increase the magnitude of the anti- 
body response to SSS-III is apparently the result of the inactivation of a cell 
type that normally serves  to suppress  the  antibody response produced after 
immunization.  There is  increasing  evidence that  such  a  homeostatic control 946  GENETIC CONTROL OF  ANTIBODY RESPONSE TO  SSS-III 
mechanism plays an  important role in immune responses  to several  antigens 
(35-42);  the  results  of preliminary  studies  reveal  that  treatment  with  ATS 
results  in  a  significant increase  in  both the  number of PFC  produced in  the 
antibody response to SSS-III and the amount of antibody made by such cells 
(24,  43).  One  must,  therefore,  consider  the  possibility  that  the  quantitative 
differences observed in this work may reflect differences between C and B mice 
in the numbers,  proportions,  or specific  activities of suppressor  and  amplifier 
cells.  If such processes are under separate  genetic control,  this would add  an 
additional complexity and introduce a new dimension to studies on the genetic 
control  of the  immune response.  We  are  currently  attempting  to  assess  the 
influence of such factors in the genetic studies described. 
SUMMARY 
The  IgM  antibody  response  to  Type  III  pneumococcal  polysaccharide 
(SSS-III) was  assessed  in  F1,  F2,  and  backcross progeny derived from high 
(BALB/cAnN)  and extremely low (CBA/HN) responding parental  strains of 
inbred  mice.  The results  of these  studies  indicated  that  a  major component 
involved in  the antibody response is X-linked, i.e.,  carried on the X  chromo- 
some;  this  component  determines  responsiveness  to  SSS-III in  an  almost 
quantal or "all-or-none" manner. Other factors, presumably autosomal genes, 
regulate the magnitude of the antibody response produced by mice possessing 
the  X-linked  gene;  these  appear  to  influence  independently  the  number  of 
antibody-producing cells  found  after  immunization  and  the  amount  of  anti- 
body made by such cells.  Strains of inbred mice varied widely in their ability 
to respond to SSS-III. Responsiveness was not associated with H-2 histocom- 
patibility type. The implications of these findings with respect to the genetic 
control of the antibody response to SSS-III are discussed. 
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